Emerging treatments for reactive cutaneous capillary endothelial proliferation

Emerging treatments for reactive cutaneous capillary endothelial proliferation

Background: Reactive cutaneous capillary endothelial proliferation (RCCEP) is a common, burdensome adverse event that occurs in up to 88% of patients treated with camrelizumab. Without treatment, RCCEP is associated with social stigma and low quality of life. However, the optimal management of RCCEP...

Full description

Bibliographic Details
Main Authors: Yi Liu, Tiancheng Chen, Chao Zhang, Weihua Pan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Indian Journal of Dermatology
Subjects:
adverse event
camrelizumab
immune checkpoint inhibitor
photochemotherapy
rccep
Online Access:http://www.e-ijd.org/article.asp?issn=0019-5154;year=2023;volume=68;issue=1;spage=85;epage=90;aulast=Liu

Internet

http://www.e-ijd.org/article.asp?issn=0019-5154;year=2023;volume=68;issue=1;spage=85;epage=90;aulast=Liu

Similar Items